Caisse de dépôt et placement du Québec (CDPQ) has agreed to invest US$500 million ($664 million) in Laboratorios Sanfer SA, a Mexico City-based pharmaceutical company. The deal, expected to close later this year, will give CDPQ a minority interest. It will support the company's expansion, both organically and through acquisitions, in Mexico and Latin America. U.S. private equity firm General Atlantic (GA), which invested in Sanfer in 2014, will retain a minority stake. With a presence in over 25 Latin American countries, Sanfer manufactures human and animal health products across more than 10 therapeutic fields.
↧